SCHEMBL31677643

SCHEMBL31677643

Oc1ccc(-c2nc3c(s2)CCCC3)cc1O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SNCA P37840 6/20 0.50
MAPT P10636 6/20 0.44
ALDH1A1 P00352 5/20 0.42
GAA P10253 5/20 0.42
KDM4E B2RXH2 4/20 0.42
LMNA P02545 4/20 0.42
HPGD P15428 4/20 0.42
SMN1; SMN2 Q16637 4/20 0.42
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42
NPSR1 Q6W5P4 2/20 0.42
GLA P06280 1/20 0.42
GUSB P08236 1/20 0.40
PPARD Q03181 2/20 0.40
PPARA Q07869 2/20 0.40
THRB P10828 1/20 0.40
APP P05067 1/20 0.39
PDK1 Q15118 2/20 0.39
FBP1 P09467 1/20 0.39
APOBEC3A P31941 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26136695 0.97 SNCA (0.50) SNCAMAPTALDH1A1GAAKDM4E
SCHEMBL1998693 0.81 PPARD (0.50) MAPTALDH1A1GAAKDM4ELMNA
SCHEMBL17332419 0.75 NPC1 (0.51) MAPTALDH1A1GAAKDM4ELMNA
SCHEMBL19954984 0.75 KDM4E (0.53) MAPTALDH1A1GAAKDM4ELMNA
SCHEMBL13667275 0.72 GAA (0.53) MAPTALDH1A1GAAKDM4ELMNA
SCHEMBL26136244 0.69 KMT2A (0.52) SNCAMAPTALDH1A1GAAKDM4E
SCHEMBL12682322 0.68 SNCA (1.00) SNCAMAPTGUSBAPP
SCHEMBL4259506 0.67 ALDH1A1 (0.52) MAPTALDH1A1GAAKDM4ELMNA
SCHEMBL8311101 0.66 KDM4E (0.48) MAPTALDH1A1GAAKDM4ELMNA
SCHEMBL3867320 0.66 PDK1 (0.54) MAPTALDH1A1GAAKDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250270199-A1 THIAZOLE DERIVATIVES AND METHODS OF USING THE SAME ARKANSAS STATE UNIV JONESBORO (US) 2025-08-28 US claimed
US-20250270199-A1 THIAZOLE DERIVATIVES AND METHODS OF USING THE SAME ARKANSAS STATE UNIV JONESBORO (US) 2025-08-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250270199-A1 THIAZOLE DERIVATIVES AND METHODS OF USING THE SAME TST, GOT2, TPMT SNCA 4758/4885MAPT 3213/4885ALDH1A1 437/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.